New 16 Gauge RF Cannula
Monday, 20 February 2012Cosman Medical's new line of curved 16-gauge radiofrequency cannula allow physicians to create larger ablation zones using standard RF electrodes. The width of a radiofrequency lesion is larger when generated using a larger gauge cannula.1,2
China's SFDA Approves the Cosman G4 RF Generator
Friday, 19 August 2011The State Food and Drug Administration (SFDA) of the People's Republic of China has approved the Cosman G4 four-electrode radiofrequency generator. The G4 generator is the first and only multi-output RF generator for pain management and functional neurosurgery registered for sale in China. It joins the wide array of Cosman products that have been registered with the SFDA since 2008.
New VP of Sales for Europe, the Middle East, and Africa
Friday, 29 July 2011Cosman Medical, a global leader in radiofrequency pain management and neurosurgery, announces the appointment of Enrico Cohen as Vice President of Sales for Europe, the Middle East, and Africa (EMEA). He has over 20 years of experience in medical device sales and product development, and over 10 years of experience in radiofrequency medicine.
Cosman Medical Launches New Website
Monday, 02 May 2011Cosman Medical, a leading manufacturer of radiofrequency (RF) generators, electrodes, and cannulas for pain management and neurosurgery, is proud to announce the launch of its new website: http://www.cosmanmedical.com. The launch follows another year of solid global expansion, particularly in the United States, Europe, South America, and Asia Pacific.
Publication Alert: Bipolar RF Lesion Size, SIJ Treatment
Wednesday, 19 January 2011In the January issue of Pain Practice, Dr. Eric Cosman, Jr, PhD, and Dr. Christian Gonzalez, MD report on an extensive ex vivo and in vivo study of parallel bipolar radiofrequency (RF) lesion geometry [1]. Bipolar RF "strip lesions" were found to be larger than cooled RF lesions as used in pain management. And, strip lesion formation was verified for electrode spacings of up to 12 mm in vivo and ex vivo.